Literature DB >> 9776686

Genetic variation as a guide to drug development.

P W Kleyn1, E S Vesell.   

Abstract

Mesh:

Substances:

Year:  1998        PMID: 9776686     DOI: 10.1126/science.281.5384.1820

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  19 in total

Review 1.  DNA patents and scientific discovery and innovation: assessing benefits and risks.

Authors:  D B Resnik
Journal:  Sci Eng Ethics       Date:  2001-01       Impact factor: 3.525

2.  Assessing the cost-effectiveness of pharmacogenomics.

Authors:  D L Veenstra; M K Higashi; K A Phillips
Journal:  AAPS PharmSci       Date:  2000

3.  Pharmacogenomics. Interview by Clare Thompson.

Authors:  W Sadee's
Journal:  BMJ       Date:  1999-11-13

4.  A novel procedure for simple and efficient genotyping of single nucleotide polymorphisms by using the Zn2+-cyclen complex.

Authors:  Emiko Kinoshita-Kikuta; Eiji Kinoshita; Tohru Koike
Journal:  Nucleic Acids Res       Date:  2002-11-15       Impact factor: 16.971

Review 5.  Racial and ethnic differences in response to medicines: towards individualized pharmaceutical treatment.

Authors:  Valentine J Burroughs; Randall W Maxey; Richard A Levy
Journal:  J Natl Med Assoc       Date:  2002-10       Impact factor: 1.798

6.  Inference from the relationships between linkage disequilibrium and allele frequency distributions of 240 candidate SNPs in 109 drug-related genes in four Asian populations.

Authors:  Pei-Chieng Cha; Ryo Yamada; Akihiro Sekine; Yusuke Nakamura; Chong-Lek Koh
Journal:  J Hum Genet       Date:  2004-09-11       Impact factor: 3.172

7.  Pharmacogenomics.

Authors:  W Sadée
Journal:  West J Med       Date:  1999-11

Review 8.  Genetic influences on rheumatoid arthritis in African Americans.

Authors:  Laura B Hughes; Larry W Moreland; S Louis Bridges
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 9.  What will be the role of pharmacogenetics in evaluating drug safety and minimising adverse effects?

Authors:  V Ozdemir; N H Shear; W Kalow
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

10.  Single-nucleotide polymorphisms can cause different structural folds of mRNA.

Authors:  L X Shen; J P Basilion; V P Stanton
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.